Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP750834.RAv0U6MYtsdUhSXaJPviNUA9IMOHeYRceQnsF2J_EL0Rw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP750834.RAv0U6MYtsdUhSXaJPviNUA9IMOHeYRceQnsF2J_EL0Rw130_assertion type Assertion NP750834.RAv0U6MYtsdUhSXaJPviNUA9IMOHeYRceQnsF2J_EL0Rw130_head.
- NP750834.RAv0U6MYtsdUhSXaJPviNUA9IMOHeYRceQnsF2J_EL0Rw130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP750834.RAv0U6MYtsdUhSXaJPviNUA9IMOHeYRceQnsF2J_EL0Rw130_provenance.
- NP750834.RAv0U6MYtsdUhSXaJPviNUA9IMOHeYRceQnsF2J_EL0Rw130_assertion evidence source_evidence_literature NP750834.RAv0U6MYtsdUhSXaJPviNUA9IMOHeYRceQnsF2J_EL0Rw130_provenance.
- NP750834.RAv0U6MYtsdUhSXaJPviNUA9IMOHeYRceQnsF2J_EL0Rw130_assertion SIO_000772 19434073 NP750834.RAv0U6MYtsdUhSXaJPviNUA9IMOHeYRceQnsF2J_EL0Rw130_provenance.
- NP750834.RAv0U6MYtsdUhSXaJPviNUA9IMOHeYRceQnsF2J_EL0Rw130_assertion wasDerivedFrom befree-20140225 NP750834.RAv0U6MYtsdUhSXaJPviNUA9IMOHeYRceQnsF2J_EL0Rw130_provenance.
- NP750834.RAv0U6MYtsdUhSXaJPviNUA9IMOHeYRceQnsF2J_EL0Rw130_assertion wasGeneratedBy ECO_0000203 NP750834.RAv0U6MYtsdUhSXaJPviNUA9IMOHeYRceQnsF2J_EL0Rw130_provenance.